Eligibility for dapagliflozin and empagliflozin in a real-world heart failure population. Thorvaldsen T, Ferrannini G, Mellbin L, Benson L, et al. J Card Fail 2022 May 9. pii: S1071-9164(22)00504.

Read + Share

Amedeo Smart

Independent Medical Education

Thorvaldsen T, Ferrannini G, Mellbin L, Benson L, et al. Eligibility for dapagliflozin and empagliflozin in a real-world heart failure population. J Card Fail 2022 May 9. pii: S1071-9164(22)00504.
PMID: 35550428